X0306 4 2022-12-28 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001190279 RODRIGUEZ RAUL R RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080 true true CEO, President Employee Stock Option (right to buy) 2.42 2022-12-28 4 A 0 200000 0 A 2032-01-24 Common Stock 200000 200000 D The Reporting Person was granted an option with a performance-based condition with respect to 200,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met. The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met. Exhibit List: Exhibit 24 - Power of Attorney /s/ Raymond Furey (Attorney-in-Fact) 2022-12-30